Quantum-Si incorporated
QSIHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Quantum-Si incorporated focuses on Medical Devices services and products. Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). At a $306.4M market cap, Quantum-Si incorporated ranks as a small-cap company within healthcare. The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS.
Market Cap
$306.4M
Beta
3.22
P/E (TTM)
—
P/E (Fwd)
-4.00
EPS (TTM)
$-0.45
EPS (Fwd)
$-0.35
ROE
-49.1%
ROA
-25.7%
Cash
$111.7M
Total Debt
$3.3M
Free CF
-$50.1M
52W Change
-38.9%
Annual Financials
Cash vs Debt
Where QSI stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, QSI finished 19.78% above its 150-day moving average ($0.91) and 14.74% above its 200-day moving average ($0.95). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is QSI overbought or oversold?
At the October 20, 2026 close, QSI's RSI(14) was 53.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $111.7M in cash comfortably exceeding the $3.3M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company is burning cash, with free cash flow at -$50.1M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -49.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity.
Quantum-Si incorporated's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing QSI.